HangzhouS MedTech's low P/E ratio is due to its lower predic...
HangzhouS MedTech's low P/E ratio is due to its lower predicted growth compared to the broader market. Investors expect limited future growth, which could potentially impede a significant increase in the stock price soon.
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more